- Genor Biopharma Co. Ltd is a biopharmaceutical powerhouse focusing on developing and commercializing oncology and autoimmune drugs.
- We have successfully developed drug candidates targeting pathways with blockbuster potentials, encompassing top three oncology targets and five out of the ten bestselling drugs globally.
- We have leveraged primarily in-house capabilities in establishing a pipeline of 15 targeted drug candidates with tremendous commercialization potentials in China that cover both proven and novel biological pathways.
Latest News
-
2023-05-29The latest research data of Lerociclib(GB491) was selected by ASCO Daily News Column, Genor Biopharma’s CDK4/6 inhibitor recognized at globe
-
2023-05-10Genor Biopharma Announces Poster of Results of the LEONARDA-1 Phase III clinical trial in advanced HR+/HER2- breast cancer at 2023 American Society of Clinical Oncology (ASCO) Annual Meeting
-
2023-03-31Genor Biopharma Releases Its Annual Results for 2022
Find Out More
